July 2026
Published Jul 7, 2026RCTsNew this week
This study evaluated the effects of SGLT2 inhibitors on cardiovascular and kidney outcomes across different levels of albuminuria. It found significant reductions in albuminuria and various adverse outcomes compared to placebo.
Interventions
SGLT2 inhibitors
Outcomes
AlbuminuriaAll-cause mortalityAtherothrombotic events+3 more
Added to Dediabetes Jul 7, 2026
View studyPublished Jul 7, 2026RCTsNew this week
This study investigated the effects of dapagliflozin on cardiovascular outcomes in diabetic patients, revealing significant changes in plasma IL-1B and ketones.
Interventions
Dapagliflozin
Outcomes
Extracellular volumeGlobal myocardial strainInterleukin-6 (IL-6)+6 more
Added to Dediabetes Jul 7, 2026
View studyPublished Jul 7, 2026RCTsNew this week
The study evaluated the effects of ertugliflozin on cardiac function in individuals with type 2 diabetes and pre-heart failure, finding significant improvements in certain cardiac metrics.
Interventions
Ertugliflozin
Outcomes
Adverse events incidenceGlobal longitudinal strainHbA1c+9 more
Added to Dediabetes Jul 7, 2026
View studyPublished Jul 7, 2026RCTsNew this week
This study evaluated the effects of finerenone on heart and kidney events in patients with chronic kidney disease and type 2 diabetes, finding significant reductions in event rates compared to placebo.
Interventions
Finerenone (nonsteroidal mineralocorticoid receptor antagonist)
Outcomes
Adverse events incidenceComposite cardiovascular events (CV death, MI, stroke, HF hospitalization)Composite cardiovascular outcome+4 more
Added to Dediabetes Jul 7, 2026
View studyPublished Jul 7, 2026RCTsNew this week
The study evaluated the effect of Finerenone on hypokalaemia in patients with chronic kidney disease and type 2 diabetes, finding a significant reduction in incidence compared to placebo.
Interventions
Finerenone (nonsteroidal mineralocorticoid receptor antagonist)
Outcomes
Arrhythmia composite outcomeComposite cardiovascular events (CV death, MI, stroke, HF hospitalization)Hypokalaemia incidence
Added to Dediabetes Jul 7, 2026
View studyPublished Jul 7, 2026RCTsNew this week
This study compared high-dose and standard-dose influenza vaccines in older adults with diabetes, finding that HD-IIV reduced hospitalizations for various diseases.
Interventions
High-dose inactivated influenza vaccine (HD-IIV)Standard-dose inactivated influenza vaccine (SD-IIV)
Outcomes
Hospitalization for any cardiorespiratory diseaseHospitalization for any cardiovascular diseaseHospitalization for influenza
Added to Dediabetes Jul 7, 2026
View studyPublished Jul 7, 2026RCTsNew this week
The Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial demonstrated that Icosapent ethyl significantly reduced cardiovascular events compared to placebo.
Interventions
Icosapent ethyl
Outcomes
Absolute cardiovascular risk reductionComposite cardiovascular events (CV death, MI, stroke, HF hospitalization)Major adverse cardiovascular events, 5-point composite
Added to Dediabetes Jul 7, 2026
View studyPublished Jul 7, 2026RCTsNew this week
This study examined the effects of intensive versus standard glycemic control on cardiovascular events in type 2 diabetes patients, finding no significant differences in certain outcomes.
Interventions
Intensive glycemic controlStandard glycemic control
Outcomes
All-cause mortalityComposite cardiovascular events (CV death, MI, stroke, HF hospitalization)
Added to Dediabetes Jul 7, 2026
View studyPublished Jul 7, 2026RCTsNew this week
This study investigated the effects of liraglutide on stroke recurrence in patients with type 2 diabetes, finding a lower rate of recurrence compared to the control group.
Outcomes
Acute pancreatitisAll-cause mortalityGastrointestinal disorders incidence+8 more
Added to Dediabetes Jul 7, 2026
View studyPublished Jul 7, 2026RCTsNew this week
This study evaluated the effects of long-term multifactorial interventions on clinical outcomes in Emirati patients with diabetes, finding significant improvements in HbA1c and LDL-C levels.
Interventions
Multifactorial interventions
Outcomes
Diastolic blood pressureEstimated glomerular filtration rateHbA1c+3 more
Added to Dediabetes Jul 7, 2026
View study